Related Experiment Video
Updated: Dec 24, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza
John F Alcorn1, Raghunandan Avula2, Anish B Chakka2
1Department of Pediatrics, University of Pittsburgh , Pittsburgh, PA, USA.
Insights
Influenza vaccination in children triggers dynamic immune responses, with gene expression changes varying by age and prior vaccination history. These transcriptomic shifts reveal insights into innate inflammation, cellular processes, and immune cell maturation following vaccination.
Area of Science:
- Immunology
- Transcriptomics
- Vaccinology
Background:
- The immune response to inactivated influenza vaccines is complex and influenced by host factors.
- Understanding post-vaccination molecular changes in children is crucial for assessing vaccine efficacy and safety.
Purpose of the Study:
- To identify and characterize transcriptomic alterations in peripheral blood mononuclear cells (PBMCs) of children after inactivated influenza vaccination.
- To investigate how age and prior vaccine history impact these molecular responses.
Main Methods:
- Blood samples were collected from children before and 3 or 7 days after receiving the 2016-2017 quadrivalent inactivated influenza vaccine.
- RNA sequencing was performed on PBMCs to analyze gene expression.
- Differential gene expression analysis was conducted, comparing time points and stratifying by age and vaccine history.
Main Results:
- A significant number of differentially expressed genes (DEGs) were observed at both 3 and 7 days post-vaccination.
- Early (Day 3) changes were dominated by innate inflammation and apoptosis pathways, while later (Day 7) changes involved cellular processes and immunoglobulin gene expression.
- Older children showed increased inflammatory gene expression at Day 3. Prior vaccination history modulated responses, including decreased phagosome and dendritic cell maturation.
Conclusions:
- Post-inactivated influenza vaccination transcriptomic responses in children are dynamic and significantly influenced by the timing of sample collection, age, and previous vaccination status.
- These findings provide a temporal molecular map of the immune response to influenza vaccination in pediatric populations.
Abstract:
The human immune response to inactivated influenza vaccine is dynamic and impacted by age and preexisting immunity. Our goal was to identify postvaccination transcriptomic changes in peripheral blood mononuclear cells from children. Blood samples were obtained before and at 3 or 7 days postvaccination with 2016-2017 quadrivalent inactivated influenza vaccine and RNA sequencing was performed. There were 1,466 differentially expressed genes (DEGs) for the Day 0-Day 3 group and 513 DEGs for the Day 0-Day 7 group. Thirty-three genes were common between the two groups. The majority of the transcriptomic changes at Day 3 represented innate inflammation and apoptosis pathways. Day 7 DEGs were characterized by activation of cellular processes, including the regulation of cytoskeleton, junctions, and metabolism, and increased expression of immunoglobulin genes. DEGs at Day 3 were compared between older and younger children revealing increased inflammatory gene expression in the older group. Vaccine history in the year prior to the study was characterized by robust DEGs at Day 3 with decreased phagosome and dendritic cell maturation in those who had been vaccinated in the previous year. PBMC responses to inactivated influenza vaccination in children differed significantly by the timing of sampling, patient age, and vaccine history. These data provide insight into the expected molecular pathways to be temporally altered by influenza vaccination in children.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024